SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000939798-19-000027
Filing Date
2019-05-24
Accepted
2019-05-24 06:14:48
Documents
4
Period of Report
2019-05-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 GTBP 8K ISSUANCE OF NOTES gtbpeightkissuanceofnotes.htm 8-K 16372
2 FORM OF NOTE exfourone.htm EX-4.1 151785
3 SECURITIES PURCHASE AGREEMENT exhibittenone.htm EX-10.1 346254
4 FORM OF REGISTRATION RIGHTS AGREEMENT exhibittentwo.htm EX-10.2 189160
  Complete submission text file 0000939798-19-000027.txt   705078
Mailing Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362
Business Address 310 N. WESTLAKE BLVD. SUITE 206 WESTLAKE VILLAGE CA 91362 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-08092 | Film No.: 19851981
SIC: 2834 Pharmaceutical Preparations